Documentos relacionados

1. Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice.
2. Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelines.
3. European Lipid Guidelines and Cardiovascular Risk Estimation: Current Status and Future Challenges.
4. [The Role of non-Statin Therapy for Lowering the Concentration of low-Density Lipoprotein Cholesterol and Reducing the Risk of Developing Atherosclerotic Cardiovascular Complications].
5. Should an LDL-Cholesterol Target-Based Approach Be Readopted?
6. Prevalence of plasma lipid disorders with an emphasis on LDL cholesterol in selected countries in the Asia-Pacific region.
7. Cholesterol Levels Should Play a More Important Role in Identifying Statin Recipients.
8. Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III.
9. QUality improvement in primary care to prevent hospitalisations and improve Effectiveness and efficiency of care for people Living with coronary heart disease (QUEL): protocol for a 24-month cluster randomised controlled trial in primary care.
10. Management of Dyslipidemias in Europe and the USA: Same Evidence, Different Conclusions? Can We Find Common Ground?